Hanna Gyllensten
SENIOR LECTURER
Learning and Leadership for Health CareAbout Hanna Gyllensten
About Hanna Gyllensten
Hanna Gyllensten is a registered pharmacist with a background in community pharmacy and as a ward pharmacist. She is PhD (Medicine) since 2014 and her thesis was exploring the economic impact of drug-related morbidity, including e.g., adverse drug reactions and sub-therapeutic effects of drug therapy. Hanna is now a senior lecturer at University of Gothenburg. She is also associated with Insurance Medicine, Karolinska institutet in Stockholm.
Research
Hannas research focuses on health economic aspects of, in particular, chronic diseases. At University of Gothenburg she conducts economic evaluations of person-centred interventions in healthcare, based on data collected within clinical trials and complemented by data from national and regional registers.
Her other research projects include mainly (register-based) observational research. The studies uses national registers, sometimes complemented by data from population survey or collected from medical records, to study e.g., societal costs resulting from disease.
Research groups
GPCC - University of Gothenburg Centre for Person-centred Care.
Health Care Transition Research Group.
Education
Health economics and priority setting in healthcare, quantitative research methods, evidence-based public health, social pharmacy.
Key words
Health economics, person-centred care, drug-related morbidity, drug safety, pharmacoepidemiology, pharmacoeconomics, public health.
-
Factors affecting adolescents’ participation in randomized controlled trials evaluating the effectiveness of healthcare interventions: the case of the STEPSTONES
project
Markus Saarijärvi, Lars Wallin, Philip Moons, Hanna Gyllensten, Ewa-Lena Bratt
BMC Medical Research Methodology - 2020-01-01 -
Modelling the cost-effectiveness of person-centred care for patients with acute coronary
syndrome
Laura Pirhonen, Hanna Gyllensten, Andreas Fors, Kristian Bolin
European Journal of Health Economics - 2020-01-01 -
Person-centred eHealth intervention for patients on sick leave due to common mental disorders: study protocol of a randomised controlled trial and process evaluation
(PROMISE)
Matilda Cederberg, Lilas Ali, Inger Ekman, K. Glise, Ingibjörg H Jonsdottir, Hanna Gyllensten, Karl Swedberg, Andreas Fors
BMJ Open - 2020-01-01 -
A national research centre for the evaluation and implementation of person-centred care: Content from the first interventional
studies
Hanna Gyllensten, Ida Björkman, Eva Jakobsson Ung, Inger Ekman, Sofie Jakobsson
Health Expectations - 2020-01-01 -
Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled
trial
Lilas Ali, Sara Wallström, Emmelie Barenfeld, Andreas Fors, E. Fredholm, Hanna Gyllensten, Karl Swedberg, Inger Ekman
BMJ Open - 2020-01-01 -
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in
Sweden.
Korinna Karampampa, Hanna Gyllensten, Fei Yang, Chantelle Murley, Emilie Friberg, Jan Hillert, Kristina Alexanderson
PharmacoEconomics - open - 2020-01-01 -
Processutvärdering av ett personcentrerat övergångsprogram för ungdomar med medfödda hjärtfel i övergång till vuxenlivet –
STEPSTONES-projektet
Markus Saarijärvi, Lars Wallin, Hanna Gyllensten, Philip Moons, Ewa-Lena Bratt
Centrum för personcentrerad vård (GPCC) 10-årsjubileumskonferens 6-7 feb 2020, Konferenscentrum Wallenberg vid Sahlgrenska akademin i Göteborg - 2020-01-01 -
Cohort study of healthcare use, costs and diagnoses from onset to 6 months after discharge for takotsubo syndrome in
Sweden.
Sara Wallström, Inger Ekman, Elmir Omerovic, Kerstin Ulin, Hanna Gyllensten
BMJ open - 2019-01-01 -
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled
Trial.
Laura Pirhonen, Kristian Bolin, Elisabeth Hansson-Olofsson, Andreas Fors, Inger Ekman, Karl Swedberg, Hanna Gyllensten
PharmacoEconomics - open - 2019-01-01 -
Room4Birth - the effect of an adaptable birthing room on labour and birth outcomes for nulliparous women at term with spontaneous labour start: study protocol for a randomised controlled superiority trial in
Sweden.
Marie Berg, Lisa Goldkuhl, Christina Nilsson, Helle Wijk, Hanna Gyllensten, Göran Lindahl, Kerstin Uvnäs Moberg, Cecily Begley
Trials - 2019-01-01 -
Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in
Sweden.
Hanna Gyllensten, Andrius Kavaliunas, Chantelle Murley, Kristina Alexanderson, Jan Hillert, Petter Tinghög, Emilie Friberg
Multiple sclerosis journal - experimental, translational and clinical - 2019-01-01 -
Transition program for adolescents with congenital heart disease in transition to adulthood: protocol for a mixed-method process evaluation study (the STEPSTONES
project).
Markus Saarijärvi, Lars Wallin, Philip Moons, Hanna Gyllensten, Ewa-Lena Bratt
BMJ open - 2019-01-01 -
Clinical relevance of alerts from a decision support system, PHARAO, for drug safety assessment in the older
adults
Khedidja Hedna, M. L. Andersson, Hanna Gyllensten, S. Hagg, Y. Bottiger
BMC Geriatrics - 2019-01-01 -
Transition program for adolescents with congenital heart disease in transition to adulthood: protocol and rationale for a mixed-methods process evaluation study (the STEPSTONES
project)
Markus Saarijärvi, Lars Wallin, Philip Moons, Hanna Gyllensten, Ewa-Lena Bratt
Knowledge Utilization (KU) Colloquium 2019, 25-28 juni, Montebello, Quebec, Canada - 2019-01-01 -
Transition program to empower adolescents with chronic conditions in their transition to adulthood: methods and rationale for the STEPSTONES
project
Markus Saarijärvi, Mariela Acuña Mora, Carina Sparud Lundin, Lars Wallin, Hanna Gyllensten, Ewa-Lena Bratt, Philip Moons
Forte Talks, 26-27 mars 2019, Stockholm - 2019-01-01 -
Economic evaluation of a person-centred care intervention in head and neck oncology: results from a randomized controlled
trial.
Hanna Gyllensten, Ingalill Koinberg, Eric Carlström, Lars-Erik Olsson, Elisabeth Hansson-Olofsson
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer - 2019-01-01 -
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical
disability.
Andrius Kavaliunas, Virginija Danylaite Karrenbauer, Hanna Gyllensten, Ali Manouchehrinia, Anna Glaser, Tomas Olsson, Kristina Alexanderson, Jan Hillert
Multiple sclerosis (Houndmills, Basingstoke, England) - 2019-01-01 -
Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working
age.
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Anders Norlund, Emilie Friberg, Jan Hillert, Olivia Ernstsson, Petter Tinghög
The European journal of health economics : HEPAC : health economics in prevention and care - 2018-01-01 -
Disposable income trajectories of working-aged individuals with diagnosed multiple
sclerosis.
Chantelle Murley, Fei Yang, Hanna Gyllensten, Kristina Alexanderson, Emilie Friberg
Acta neurologica Scandinavica - 2018-01-01 -
Costs and quality of life by disability among people with multiple sclerosis: a register-based study in
Sweden.
Hanna Gyllensten, Andrius Kavaliunas, Kristina Alexanderson, Jan Hillert, Petter Tinghög, Emilie Friberg
Multiple sclerosis journal - experimental, translational and clinical - 2018-01-01 -
Increasing return-to-work among people on sick leave due to common mental disorders: design of a cluster-randomized controlled trial of a problem-solving intervention versus care-as-usual conducted in the Swedish primary health care system
(PROSA)
Elisabeth Björk Brämberg, Kristina Holmgren, U. Bultmann, Hanna Gyllensten, J. Hagberg, L. Sandman, G. Bergstrom
BMC Public Health - 2018-01-01 -
Lifestyle intervention in pregnant women with BMI
≥30
Karin Haby, Marie Berg, Hanna Gyllensten, Ragnar Hanås, Åsa Premberg
NEON, The Network in Epidemiology and Nutrition. From evidence to practice. April 18-19 2018 - 2018-01-01 -
Mighty Mums - a Lifestyle intervention at primary care level reduces gestational weiht gain in women with
obesity
Karin Haby, Marie Berg, Hanna Gyllensten, Ragnar Hanås, Åsa Premberg
BMC Obesity - 2018-01-01 -
Comparing costs of illness of multiple sclerosis in three different years: A population-based
study.
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Emilie Friberg, Jan Hillert, Petter Tinghög
Multiple sclerosis - 2018-01-01 -
Comparing Methods for Estimating Direct Costs of Adverse Drug
Events
Hanna Gyllensten, A. K. Jonsson, K. M. Hakkarainen, S. Svensson, S. Hagg, C. Rehnberg
Value in Health - 2017-01-01 -
Healthcare utilization and costs after takotsubo
syndrome
Sara Wallström, Hanna Gyllensten, Kerstin Ulin, Inger Ekman
International Forum on Quality and Safety in Healthcare - 2017-01-01 -
Hospitalization, costs and diagnosis in patients with takotsubo
syndrome
Sara Wallström, Inger Ekman, Kerstin Ulin, Hanna Gyllensten
European Heart Journal, vol. 38, suppl_1, ehx501. P615 - 2017-01-01 -
Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among
payers.
Jennie Natanaelsson, Katja M Hakkarainen, Staffan Hägg, Karolina Andersson Sundell, Max Petzold, Clas Rehnberg, Anna K Jönsson, Hanna Gyllensten
Research in social & administrative pharmacy : RSAP - 2017-01-01 -
Income in Multiple Sclerosis Patients with Different Disease
Phenotypes.
Andrius Kavaliunas, Ali Manouchehrinia, Virginija Danylaite Karrenbauer, Hanna Gyllensten, Anna Glaser, Kristina Alexanderson, Jan Hillert
PloS one - 2017-01-01 -
How does work disability of patients with MS develop before and after diagnosis? A nationwide cohort study with a reference
group
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Jan Hillert, Petter Tinghög
BMJ Open - 2016-01-01 -
Cost-effectiveness of the behavioral antenatal care intervention programme Mighty
Mums
Hanna Gyllensten, Karin Haby, Marie Berg, Åsa Premberg, Elisabeth Hansson-Olofsson
European Obesity Summit (EOS) - Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1-4, 2016. Obesity Facts. - 2016-01-01 -
Cost of illness of Multiple Sclerosis - A systematic
review
Olivia Ernstsson, Hanna Gyllensten, Kristina Alexanderson, Petter Tinghög, Emilie Friberg, Anders Norlund
PLoS ONE - 2016-01-01 -
Effectiveness of person-centred care after acute coronary syndrome in relation to educational level: Subgroup analysis of a two-armed randomised controlled
trial
Andreas Fors, Hanna Gyllensten, Karl Swedberg, Inger Ekman
International journal of cardiology - 2016-01-01 -
Person-centred care after acute coronary syndrome is effective in persons with lower socioeconomic
position
Andreas Fors, Hanna Gyllensten, Karl Swedberg, Inger Ekman
International Forum on Quality and Safety in Healthcare, 12-15 April 2016, Gothenburg, Sweden - 2016-01-01 -
Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple
Medications?
K. Hedna, K. M. Hakkarainen, Hanna Gyllensten, A. K. Jonsson, Karolina Andersson Sundell, Max Petzold, S. Hagg
Plos One - 2015-01-01 -
Pharmacoepidemiology at Nordic School of Public Health NHV: Examples from 1999 to
2014
C. S. Lundborg, Hanna Gyllensten, K. Hedna, K. M. Hakkarainen, E. Lesen, Karolina Andersson Sundell
Scandinavian Journal of Public Health - 2015-01-01 -
Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based
study
K. Hedna, Katja M Hakkarainen, Hanna Gyllensten, A. K. Jonsson, Max Petzold, S. Hagg
European Journal of Clinical Pharmacology - 2015-01-01 -
Prevalence, nature and potential preventability of adverse drug events - A population-based medical record study of 4970
adults.
Katja M Hakkarainen, Hanna Gyllensten, A K Jönsson, Karolina Andersson Sundell, Max Petzold, S Hägg
British journal of clinical pharmacology - 2014-01-01 -
Economic Impact of Adverse Drug Events – A Retrospective Population-Based Cohort Study of 4970
Adults
Hanna Gyllensten, Katja M Hakkarainen, Staffan Hägg, Anders Carlsten, Max Petzold, Clas Rehnberg, Anna K Jönsson
PLoS ONE - 2014-01-01 -
Cost of illness of patient-reported adverse drug events: a population-based cross-sectional
survey.
Hanna Gyllensten, Clas Rehnberg, Anna K Jönsson, Max Petzold, Anders Carlsten, Karolina Andersson Sundell
BMJ open - 2013-01-01 -
How are the costs of drug-related morbidity measured?: a systematic literature
review.
Hanna Gyllensten, Anna K Jönsson, Clas Rehnberg, Anders Carlsten
Drug safety - 2012-01-01 -
Modelling drug-related morbidity in Sweden using an expert panel of
physicians.
Katja M Hakkarainen, Daniel Alström, Staffan Hägg, Anders Carlsten, Hanna Gyllensten
European journal of clinical pharmacology - 2012-01-01 -
Modelling drug-related morbidity in Sweden using an expert panel of
pharmacists'.
Hanna Gyllensten, Katja M Hakkarainen, Anna K Jönsson, Karolina Andersson Sundell, Staffan Hägg, Clas Rehnberg, Anders Carlsten
International journal of clinical pharmacy - 2012-01-01